Search
Chemeq founder Graham Melrose.

Chemeq founder plans $5m IPO

A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Transactions

15/02/19
$0 Issued
09/03/17
$20k Sold
16/01/17
$0 Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer